Emily K Bergsland

19PUBLICATIONS
88CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMolecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 28, 2026
Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

|Mar 26, 2026
Characterization of small intestinal neuroendocrine tumorlets.

Akitada Yogo, Naoki Akanuma, Grace E Kim

|Sep 03, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Jan 15, 2025
Factors associated with grade progression in pancreatic neuroendocrine tumors.

Stephanie J Wang, Wesley Kidder, Nancy M Joseph

|Jun 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).

Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro

|Jun 12, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.

Erica S Tsang, Mallika S Dhawan, Romain Pacaud

Pageof 4

Frequent Collaborators

4 joint publications

Arvind N Dasari

2 joint publications

Stephanie J Wang

2 joint publications

Erin B Kennedy

2 joint publications

Mei Sheng Duh